In some New York neighborhoods, the housing stock is great, but turnover is so low, word of mouth is the best search engine.
NYS Entity Status
NYS Filing Date
AUGUST 19, 2014
NYS DOS ID#
NYS Entity Type
FOREIGN LIMITED PARTNERSHIP
2014 - ALDER HILL MANAGEMENT LP
Around the Web
- Neighborhoods That Play Hard to Get
By STEFANOS CHEN - Friday Aug 11, 2017
- Jemele Hill’s Trump comments have turned into an ESPN firestorm
By Mark W. Sanchez - Wednesday Sep 13, 2017
The only thing that unites both sides of the Jemele Hill controversy is a common fury at ESPN. In neither apologizing nor announcing a suspension — while simultaneously distancing itself – ESPN has managed to enrage just about everyone who has seen the “SportsCenter” anchor’s Tuesday night rant about President Trump. “We are with you...
- Is Luis Severino suddenly the most prized pitcher in NY?
By Ken Davidoff - Sunday Aug 6, 2017
CLEVELAND — Do we have a new King of the Hill in New York? You’re starting a third team in the Tri-State area — let’s call them the Paramus Mall Rats — and you get to choose one pitcher from either the Yankees or the Mets. Whom do you choose? You have to give ultra-serious...
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.
- Chick-fil-A manager tricked in phone scam by thief posing as CFO
By Fox News - Monday Aug 7, 2017
A Chick-fil-A manager in Chino Hills, Calif., was robbed of some cash — and maybe a little dignity — on Thursday of last week. According to a police report, the Chick-fil-A manager received a phone call from a man claiming to be the chief executive officer of Chick-fil-A sometime around 6:15 p.m., the Press-Enterprise reports....
- Teva Seeks to Keep Pace in Migraine Drug Race With Trial Results
By Frank Vinluan - Wednesday May 31, 2017
An experimental Teva Pharmaceutical migraine drug has met the main goals of a late-stage clinical trial, keeping the drugmaker in the race to bring to the market a product that prevents migraine headaches instead of treating them after they start. Teva (NYSE: TEVA) reported Wednesday that its drug fremanezumab reduced the number of days during […]